There are many different examples, but essentially by understanding the genetic basis of bacterial and viral pathology, one can develop new treatments to specifically target the proteins that are the basis of the pathological condition.

These can include antibody development of specific proteins and small molecules that block critical reactions in the pathogen's metabolic pathways.